951502, Acrometrix Genotyping HIV RT/PR Mutant Control

Hazard statements (CLP)

H370

Code

Statements

H370

Causes damage to organs

2.1 Classification of the substance or mixture

SECTION 2 - HAZARDS IDENTIFICATION …continued Globally Harmonized Specific Target Organ Toxicity (single exposure) - Category 1. System [GHS] Other/Supplemental Mixture not yet fully tested

Signal word

Danger

Hazard statements

H370 - Causes damage to immune system handling. P270 - Do not eat, drink or smoke when using this product. P307 + P311 - IF exposed: Call a POISON CENTER or doctor/physician. P321 - Specific treatment (see First Aid information on product label and/or Section 4 of the SDS). P405 - Store locked up. P501 - Dispose of contents/container to location in accordance with local/regional/national/international regulations. Additional elements

Precautionary statements

P260 - Do not breathe dust/mist/vapors/spray. P264 - Wash hands thoroughly after

2.3 Other hazards

The potential health hazards associated with exposure/handling of this mixture are unknown; no data specific for the mixture were identified. The following data describe the hazards of individual ingredients, where applicable. Primary hazards associated with transmission of and/or exposure to live virus: Needlestick, contaminated sharp objects, and/or direct contact of non-intact skin or mucous membranes with HIV-infected specimens/tissues. This product/mixture contains human source material and should be treated/ handled as a potential biohazard. All such human source material has been derived from donors tested individually and shown by FDA approved methods to be free from antibodies to Human Immune Deficiency Virus and Hepatitis B and C. As no test method can offer complete assurance that these or other infectious agents are not present, this product should be handled using standard biosafety precautions. Infection with HIV is transmitted from person to person by contact with infected body fluids. It also occurs with accidental injection (i.e., needlesticks), or exposure to cut/broken skin. Perinatal transmission may occur from mother to baby SECTION 2 - HAZARDS IDENTIFICATION …continued Other hazards …continued The clinical features of HIV infection vary depending on the stage of the disease. Acute infection is accompanied by non-specific "flu-like" and "mononucleosis- like" symptoms such as myalgia, arthralgia, diarrhea, nausea, vomiting, headache, hepatosplenomegaly, weight loss, and neurological symptoms. Note This mixture is classified as hazardous under GHS as implemented by Regulation EC No 1272/2008 (EU CLP), WHMIS 2015 (Health Canada), and Hazard Communication Standard No. 1910.1200 (US OSHA).